Abstract
The discovery of drugs for diseases of the central nervous system (CNS) faces high attrition rates in clinical trials. Neural diseases are extremely complex in nature and typically associated with multiple drug targets. A conception of multi-target directed ligands (MTDL), widely applied to the discovery of cancer pharmaceuticals, may be a perspective solution for CNS diseases. Special bioinformatics approaches have been developed which can assist the medicinal chemists in identification and structural optimization of MTDL. In this review, we analyze the current status of the development of multitarget approaches in quantitative structure-activity relationships (mt-QSAR) for CNS drug discovery; and describes applications of multi-target approaches in molecular modelling (which can be called mt-MM), as well as perspectives for multi-target approaches in bioinformatics in relation to Alzheimer’s disease.
Keywords: Multi-target, MTDL, Alzheimer's disease, molecular modelling, QSAR, cheminformatics, bioinformatics.
Current Medicinal Chemistry
Title:Applications of Multi-Target Computer-Aided Methodologies in Molecular Design of CNS Drugs
Volume: 25 Issue: 39
Author(s): Oleg A. Raevsky, Azat Mukhametov, Veniamin Y. Grigorev, Alexey Ustyugov, Shwu-Chen Tsay, Reuben Jih-Ru Hwu, Nagendra Sastry Yarla, Vadim V. Tarasov, Gjumrakch Aliev*Sergey O. Bachurin*
Affiliation:
- Department of Biomedical and Biological Chemistry, Institute of Physiologically Active Compounds, Russian Academy of Science, 142432, Chernogolovka, Moscow region,Russian Federation
- Department of Biomedical and Biological Chemistry, Institute of Physiologically Active Compounds, Russian Academy of Science, 142432, Chernogolovka, Moscow region,Russian Federation
Keywords: Multi-target, MTDL, Alzheimer's disease, molecular modelling, QSAR, cheminformatics, bioinformatics.
Abstract: The discovery of drugs for diseases of the central nervous system (CNS) faces high attrition rates in clinical trials. Neural diseases are extremely complex in nature and typically associated with multiple drug targets. A conception of multi-target directed ligands (MTDL), widely applied to the discovery of cancer pharmaceuticals, may be a perspective solution for CNS diseases. Special bioinformatics approaches have been developed which can assist the medicinal chemists in identification and structural optimization of MTDL. In this review, we analyze the current status of the development of multitarget approaches in quantitative structure-activity relationships (mt-QSAR) for CNS drug discovery; and describes applications of multi-target approaches in molecular modelling (which can be called mt-MM), as well as perspectives for multi-target approaches in bioinformatics in relation to Alzheimer’s disease.
Export Options
About this article
Cite this article as:
Raevsky A. Oleg , Mukhametov Azat , Grigorev Y. Veniamin , Ustyugov Alexey , Tsay Shwu-Chen , Jih-Ru Hwu Reuben , Yarla Sastry Nagendra , Tarasov V. Vadim , Aliev Gjumrakch *, Bachurin O. Sergey *, Applications of Multi-Target Computer-Aided Methodologies in Molecular Design of CNS Drugs, Current Medicinal Chemistry 2018; 25 (39) . https://dx.doi.org/10.2174/0929867324666170920154111
DOI https://dx.doi.org/10.2174/0929867324666170920154111 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanostructured Lipid Carriers for Intranasal Administration of Olanzapine in the Management of Schizophrenia
Current Molecular Pharmacology MTDL Design Strategy in the Context of Alzheimers Disease: From Lipocrine to Memoquin and Beyond
Current Pharmaceutical Design Effects of Prefrontal 40 Hz-Centered EEG Band Neurofeedback on Emotional State and Cognitive Functions in Adolescents
Adolescent Psychiatry fMRI Simulator Training to Suppress Head Motion
Neuroscience and Biomedical Engineering (Discontinued) Resveratrol: A Multifunctional Cytoprotective Molecule
Current Pharmaceutical Biotechnology Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery
Current Pharmaceutical Design Editorial
Current Nutrition & Food Science Clinical and Pathophysiological Relations Between Migraine and Mood Disorders
Current Psychiatry Reviews Recent Updates of N-Type Calcium Channel Blockers with Therapeutic Potential for Neuropathic Pain and Stroke
Current Topics in Medicinal Chemistry Prevalence of Anxiety During Pregnancy in Women with Previous Spontaneous Abortions
Current Women`s Health Reviews Small Molecule Modulation of p75 Neurotrophin Receptor Functions
CNS & Neurological Disorders - Drug Targets The Association between Migraine and Depression based on miRNA Biomarkers and Cohort Studies
Current Medicinal Chemistry “Reports of an Addiction”: Therapeutic Intervention with a Young Adult with Cannabis Dependence
Adolescent Psychiatry Inhibition of Ceramide Metabolism Key Enzymes and its Implication in Cell Physiology and Pathology
Current Enzyme Inhibition Meet Our Editorial Board Member
Current Psychiatry Reviews Perioperative Management of Obese Parturients
Current Women`s Health Reviews Reposition of the Fungicide Ciclopirox for Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Phytochemical Informatics and Virtual Screening of Herbs Used in Chinese Medicine
Current Pharmaceutical Design Inhibitors of Phosphoinositol 3 Kinase and NFκB for the Treatment of Chronic Obstructive Pulmonary Disease
Recent Patents on Inflammation & Allergy Drug Discovery 5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications
Current Medicinal Chemistry